Cuprina Holdings [Cayman] Limited (CUPR)

$0.33 -0.01 (-2.43%)
Market Cap 7.17M
Revenue (ttm) 40,000.00
Net Income (ttm) -1.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,875.00%
Debt to Equity Ratio 0.02
Volume 38,300
Avg Vol 228,250
Day's Range N/A - N/A
Shares Out 21.00M
Stochastic %K 8%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the va...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 65 8512 7275
Address:
Blk 1090, Lower Delta Road #06-08, Singapore, Singapore
LudwigVanBeethoven
LudwigVanBeethoven Mar. 20 at 5:16 PM
$CUPR traded by private invitation only ;-) OK, sucks. Fundamentals not existing, pure pre-revenue and expansion bioTech trade. Last PR didn't work out.
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 18 at 2:57 PM
$CUPR flies or frogs, now needs a crazy run up or they need to tell SH how they can do a RS on just like 22M shares.
0 · Reply
Heidne
Heidne Mar. 16 at 4:42 PM
$CUPR Cuprina's "Edge" vs. The Competitors For Cuprina to succeed, they need to win on two points where the giants are weak: Price: Larval therapy and collagen from frogs can theoretically be produced cheaper than the high-tech cell products from Organogenesis. Religious/Cultural factors: Since Cuprina's collagen comes from frogs (and not pigs or cows), it may be easier to market in Muslim countries (the halal aspect), which explains their focus on Saudi Arabia.
0 · Reply
Heidne
Heidne Mar. 16 at 4:34 PM
$CUPR Some short-term models see a potential recovery towards $0.68–0.89 in 2026.
0 · Reply
Heidne
Heidne Mar. 16 at 6:43 AM
$CUPR Strategic Expansion and Market Growth (2025-2026) Expansion in the Middle East (MENA): The company recently achieved a major milestone by receiving official product classification from the Saudi Food and Drug Authority (SFDA) for its flagship product MEDIFLY (medical fly larva therapy). This opens the door for commercial distribution in the Saudi Arabian healthcare network. US Market: Cuprina is currently preparing an FDA 510(k) application for MEDIFLY, which is crucial to gaining access to the US wound care market.
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 13 at 4:04 PM
$CUPR *smh*
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 12 at 1:52 PM
$CUPR possible they consumed the float for Project 5 for the anniversary. Project 5/sh.
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 11 at 6:06 PM
$CUPR approaching its 1st anniversary on the exchange 4/10, very rough time. Maybe make it back to IPO price just for fun? Would be a blast :)
1 · Reply
Heidne
Heidne Mar. 11 at 5:41 PM
$CUPR Cuprina Holdings Secures Saudi FDA Classification for MEDIFLY and Appoints Dr. Enming Yong to Advisory Board Cuprina Holdings (Cayman) Limited (NASDAQ: CUPR) announced that its 49‑percent owned associate, Cuprina MENA Co. Ltd, has received official product classification from the Saudi Food and Drug Authority (SFDA) for MEDIFLY, the company’s medical‑grade maggot debridement therapy. The SFDA classified MEDIFLY as a Medical Device–Drug combination product, placing the primary mode of action under the medical device framework.
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 11 at 5:41 PM
$CUPR on 3/3 and 3/4 ~7.5M shares were changing hands, more than float (7.3M). Somebody is happy now.
0 · Reply
Latest News on CUPR
Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board

Mar 11, 2026, 8:30 AM EDT - 10 days ago

Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board

Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Nov 28, 2025, 8:30 AM EST - 4 months ago

Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies

Oct 27, 2025, 8:40 AM EDT - 5 months ago

Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET

Oct 6, 2025, 8:30 AM EDT - 5 months ago

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET

Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology

Sep 9, 2025, 8:05 AM EDT - 6 months ago

Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology

Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets

Aug 11, 2025, 12:28 PM EDT - 7 months ago

Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets

EPSM FLYE MIMI QMMM STFS

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

Jul 21, 2025, 9:00 AM EDT - 8 months ago

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

Cuprina Provides Update on Research Studies with Three Leading Education Institutes

Jun 30, 2025, 8:00 AM EDT - 9 months ago

Cuprina Provides Update on Research Studies with Three Leading Education Institutes

Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries

Jun 4, 2025, 8:00 AM EDT - 10 months ago

Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries

Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering

May 8, 2025, 1:05 PM EDT - 11 months ago

Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering

Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.

May 5, 2025, 12:29 PM EDT - 11 months ago

Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

May 5, 2025, 12:27 PM EDT - 11 months ago

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering

May 5, 2025, 12:24 PM EDT - 11 months ago

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering

Singapore-based Cuprina Holdings, which makes wound care products, files for a $10 million US IPO

Mar 7, 2024, 9:55 PM EST - 2 years ago

Singapore-based Cuprina Holdings, which makes wound care products, files for a $10 million US IPO

Cuprina Holdings IPO Registration Document (F-1)

Mar 7, 2024, 4:09 PM EST - 2 years ago

Cuprina Holdings IPO Registration Document (F-1)

LudwigVanBeethoven
LudwigVanBeethoven Mar. 20 at 5:16 PM
$CUPR traded by private invitation only ;-) OK, sucks. Fundamentals not existing, pure pre-revenue and expansion bioTech trade. Last PR didn't work out.
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 18 at 2:57 PM
$CUPR flies or frogs, now needs a crazy run up or they need to tell SH how they can do a RS on just like 22M shares.
0 · Reply
Heidne
Heidne Mar. 16 at 4:42 PM
$CUPR Cuprina's "Edge" vs. The Competitors For Cuprina to succeed, they need to win on two points where the giants are weak: Price: Larval therapy and collagen from frogs can theoretically be produced cheaper than the high-tech cell products from Organogenesis. Religious/Cultural factors: Since Cuprina's collagen comes from frogs (and not pigs or cows), it may be easier to market in Muslim countries (the halal aspect), which explains their focus on Saudi Arabia.
0 · Reply
Heidne
Heidne Mar. 16 at 4:34 PM
$CUPR Some short-term models see a potential recovery towards $0.68–0.89 in 2026.
0 · Reply
Heidne
Heidne Mar. 16 at 6:43 AM
$CUPR Strategic Expansion and Market Growth (2025-2026) Expansion in the Middle East (MENA): The company recently achieved a major milestone by receiving official product classification from the Saudi Food and Drug Authority (SFDA) for its flagship product MEDIFLY (medical fly larva therapy). This opens the door for commercial distribution in the Saudi Arabian healthcare network. US Market: Cuprina is currently preparing an FDA 510(k) application for MEDIFLY, which is crucial to gaining access to the US wound care market.
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 13 at 4:04 PM
$CUPR *smh*
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 12 at 1:52 PM
$CUPR possible they consumed the float for Project 5 for the anniversary. Project 5/sh.
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 11 at 6:06 PM
$CUPR approaching its 1st anniversary on the exchange 4/10, very rough time. Maybe make it back to IPO price just for fun? Would be a blast :)
1 · Reply
Heidne
Heidne Mar. 11 at 5:41 PM
$CUPR Cuprina Holdings Secures Saudi FDA Classification for MEDIFLY and Appoints Dr. Enming Yong to Advisory Board Cuprina Holdings (Cayman) Limited (NASDAQ: CUPR) announced that its 49‑percent owned associate, Cuprina MENA Co. Ltd, has received official product classification from the Saudi Food and Drug Authority (SFDA) for MEDIFLY, the company’s medical‑grade maggot debridement therapy. The SFDA classified MEDIFLY as a Medical Device–Drug combination product, placing the primary mode of action under the medical device framework.
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 11 at 5:41 PM
$CUPR on 3/3 and 3/4 ~7.5M shares were changing hands, more than float (7.3M). Somebody is happy now.
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Mar. 11 at 5:27 PM
$CUPR congrats to the device classification, will bring in the license and sales. I know, horrible times - still or especially, these wound therapies are good for the people.
0 · Reply
Heidne
Heidne Mar. 11 at 3:20 PM
$CUPR https://www.linkedin.com/posts/skyline-corporate-communications-group-llc_skylinecorporatecommunications-cuprina-biotech-activity-7437512927722508288-gKkW?utm_source=share&utm_medium=member_ios&rcm=ACoAAB8J6doBjrZteH3hc27hfKDzdcGbS_6Mj-E
0 · Reply
SkylineCCG
SkylineCCG Mar. 11 at 3:01 PM
A key milestone for our client Cuprina Holdings $CUPR Cuprina announced that its 49%-owned associate, Cuprina MENA Co. Ltd, received product classification from the Saudi Food and Drug Authority (SFDA) for MEDIFLY, its medical-grade maggot debridement therapy used in chronic wound care. The classification enables the Company to move forward with the requirements needed for commercial distribution across Saudi Arabia, supporting its expansion across the MENA region. The Company also strengthened its Medical and Scientific Advisory Board with the appointment of Dr. Enming Yong, a respected endocrinology specialist based in Singapore. #SkylineCorporateCommunications #ClientNews #Biotech #Healthcare #CUPR 🔗 Learn more about the announcement here: https://finance.yahoo.com/news/cuprina-holdings-announces-key-regulatory-123000110.html Skyline is paid by $CUPR for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 11 at 12:31 PM
$CUPR - Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board
0 · Reply
Heidne
Heidne Mar. 9 at 7:46 AM
$CUPR https://www.linkedin.com/posts/cuprina-wound-care-solutions_mdt-cuprina-woodlandshospital-activity-7436663478028840960-qBW4?utm_source=share&utm_medium=member_ios&rcm=ACoAAB8J6doBjrZteH3hc27hfKDzdcGbS_6Mj-E
0 · Reply
davidwolf0
davidwolf0 Mar. 9 at 6:49 AM
$CUPR wtf at this overnight price
0 · Reply
Mrpringl
Mrpringl Mar. 4 at 9:03 PM
$CUPR 🥶🥶🥶🥶
0 · Reply
Stackdoe101
Stackdoe101 Mar. 4 at 8:23 PM
$CUPR 🫡✨
0 · Reply
Faykar
Faykar Mar. 4 at 8:04 PM
$CUPR weak hands shaked out.
0 · Reply
Agguie
Agguie Mar. 4 at 1:03 AM
$CUPR feels like something. picked up a couple just in case
0 · Reply
Faykar
Faykar Mar. 3 at 11:26 PM
$CUPR Lfg 🚀to $10
0 · Reply
Holdconviction
Holdconviction Mar. 3 at 11:20 PM
$CUPR Damn
0 · Reply